Two Sigma Investments’s Kindred Biosciences, Inc. KIN Stock Holding History

Two Sigma Investments’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-130,655	Closed	-$1.2M	–	4932
2021 Q2	$1.2M	Buy	130,655 +12,347	+10%	+$71.8K	﹤0.01%	2319
2021 Q1	$588K	Buy	118,308 +89,916	+317%	+$434K	﹤0.01%	2788
2020 Q4	$122K	Buy	+28,392	New	+$115K	﹤0.01%	3194
2020 Q3	–	Sell	-22,415	Closed	-$101K	–	3738
2020 Q2	$101K	Buy	+22,415	New	+$100K	﹤0.01%	2784
2019 Q2	–	Sell	-56,587	Closed	-$519K	–	3806
2019 Q1	$519K	Buy	+56,587	New	+$575K	﹤0.01%	2246
2018 Q4	–	Sell	-86,980	Closed	-$1.21M	–	3689
2018 Q3	$1.21M	Buy	86,980 +28,708	+49%	+$388K	﹤0.01%	1839
2018 Q2	$621K	Buy	+58,272	New	+$568K	﹤0.01%	2497
2017 Q3	–	Sell	-11,596	Closed	-$100K	–	3348
2017 Q2	$100K	Buy	+11,596	New	+$83.2K	﹤0.01%	2868

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Two Sigma Investments's KIN Position: Q3 2021 in Review

Two Sigma Investments sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 130,655 shares — an estimated $1.2M sold.

Two Sigma Investments first reported a position in KIN in Q2 2017 and held it in 8 quarters. The position peaked at $1.21M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Two Sigma Investments reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Two Sigma Investments sold 130,655 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.2M.
Two Sigma Investments first reported a position in Kindred Biosciences, Inc. in Q2 2017 and held it in 8 quarters.
Two Sigma Investments's Kindred Biosciences, Inc. position peaked at $1.21M in Q3 2018.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.